A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma : OSR Holdings

At OSR Holdings, we are committed to advancing transformative therapies grounded in rigorous scientific research. Below are selected publications and conference abstracts that provide scientific context for our programs and the underlying biology of our pipeline candidates.

Events & Presentation copy

4 Sep 2025

A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma

Clinical and histopathological analyses of VEGF receptors peptide vaccine in patients with primary glioblastoma - a case series Vaximm's Poster Presentation for VXM01 at TIMO XIX 2025

List New post